Concurrent Investment Advisors LLC Increases Stock Position in Omega Healthcare Investors, Inc. $OHI

Concurrent Investment Advisors LLC boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 7.4% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,853 shares of the real estate investment trust’s stock after purchasing an additional 2,124 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Omega Healthcare Investors were worth $1,131,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Omega Healthcare Investors by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock worth $1,506,250,000 after purchasing an additional 1,492,904 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Omega Healthcare Investors by 2.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust’s stock worth $156,162,000 after purchasing an additional 114,665 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after purchasing an additional 165,554 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Omega Healthcare Investors by 6.4% in the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust’s stock worth $118,930,000 after purchasing an additional 188,481 shares in the last quarter. Finally, AQR Capital Management LLC lifted its stake in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock worth $108,989,000 after purchasing an additional 2,322,878 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

Shares of NYSE:OHI opened at $40.13 on Thursday. The company has a market capitalization of $11.84 billion, a price-to-earnings ratio of 24.77, a PEG ratio of 1.85 and a beta of 0.70. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The firm’s 50-day moving average is $41.56 and its 200 day moving average is $38.84. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm’s revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.7%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio is currently 165.43%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OHI. Royal Bank Of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research report on Thursday, August 7th. Truist Financial upped their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research report on Wednesday, September 3rd. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Mizuho upped their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Finally, Scotiabank upped their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Seven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Moderate Buy” and a consensus price target of $44.44.

Insider Buying and Selling

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.